Arca
Skip to content
Tools
Tools

Label Changes: Sirolimus Solution (sirolimus)

A drug's label (its prescribing information) is revised many times after approval: new warnings, new uses, new doses. DailyMed keeps every version. Pick a drug to see them all and what changed between any two.

Every version of the Sirolimus Solution label DailyMed has published, from Mylan Pharmaceuticals Inc., and what changed between any two of them, section by section. Current label on DailyMed.

  • Versions on DailyMed: 15
  • Sections changed, version 19 to 20: 5

What changed from version 19 to version 20

Oct 14, 2026 to Oct 26, 2026, as published on DailyMed. Added text is underlined in green, removed text struck through in red.
  1. Drug interactionsChanged · punctuation or symbols only
  2. Patient counseling informationChanged · 15 words added, 13 removed
  3. Medication guideChanged · 2 words added, 2 removed
  4. Instructions for useChanged · 4 words added, 4 removed
  5. PRINCIPAL DISPLAY PANEL - Kit CartonChanged · punctuation or symbols only

Drug interactions

Changedpunctuation or symbols only
9 unchanged lines
Exercise caution when using sirolimus with drugs or agents that are modulators of CYP3A4 and P-gp. The dosage of sirolimus and/or the co-administered drug may need to be adjusted [see Clinical Pharmacology (12.3) ].
• Drugs that could increase sirolimus blood concentrations: Bromocriptine, cimetidine, cisapride, clotrimazole, danazol, diltiazem, fluconazole, letermovir, protease inhibitors (e.g., HIV and hepatitis C that include drugs such as ritonavir, indinavir, boceprevir, and telaprevir), metoclopramide, nicardipine, troleandomycin, verapamil
•Drugs and other agents that could decrease sirolimus concentrations: Carbamazepine, phenobarbital, phenytoin, rifapentine, St. John's Wort (Hypericum perforatum)
3 unchanged lines

Patient counseling information

Changed15 words added, 13 removed
1 unchanged line
Advise patients, their families, and their caregivers to read the Medication Guide and Instructions for Use and assist them in understanding its contents. The complete text of the Medication Guide and Instructions for Use are reprinted at the end of the document.
See FDA-Approved Medication Guide and Instructions for Use.
See Error! Hyperlink reference not valid. and Instructions for Use.
17.1 Dosage
Patients should be given complete dosage instructions [see FDA-ApprovedError! MedicationHyperlink Guidereference not valid. ].
17.2 Skin Cancer Events
5 unchanged lines

Medication guide

Changed2 words added, 2 removed
8 unchanged lines
| •swelling of your face, eyes, or mouth •trouble breathing or wheezing •throat tightness | •chest pain or tightness •feeling dizzy or faint •rash or peeling of your skin
• Swelling (edema). Fluid may collect in your hands and feet and in various tissues of your body, including in the sac around your heart or lungs. Call your doctor if you have trouble breathing. • Poor wound healing. Sirolimus may cause your wounds to heal slowly or not heal well. Tell your doctor if you have any redness or drainage, your wound does not heal, or the wound opens up. • Increased levels of cholesterol and triglycerides (lipids or fat) in your blood. Your doctor should do blood tests to check your lipids during treatment with sirolimus. Your doctor may prescribe treatment with diet, exercise, or medicine if your lipid levels are too high. During treatment with sirolimus, your blood levels of cholesterol and triglycerides may remain high even if you follow your prescribed treatment plan. • Effects on kidney function. When sirolimus is taken with cyclosporine (Gengraf, Neoral, Sandimmune), the function of your transplanted kidney may be affected. Your doctor should regularly do tests to check your kidney function while you are taking sirolimus with cyclosporine (Gengraf, Neoral, Sandimmune). • Increased protein in your urine. Your doctor may regularly test your urine protein. • Increased risk for viral infections. •CertainoCertain viruses can live in your body and cause active infections when your immune system is weak. BK virus can affect how your kidney works and cause your transplanted kidney to fail. •AoA certain virus can cause a rare serious brain infection called Progressive Multifocal Leukoencephalopathy (PML). PML usually causes death or severe disability. Call your doctor right away if you notice any new or worsening medical problems such as: •▪confusion •▪sudden change in thinking, walking, strength on one side of your body •▪other problems that have lasted over several days • Lung or breathing problems. This can sometimes lead to death. Tell your doctor if you have a new or worsening cough, shortness of breath, difficulty breathing or any new breathing problems. Your doctor may need to stop sirolimus or lower your dose. • Blood clotting problems. When sirolimus is taken with cyclosporine or tacrolimus, you may develop a blood clotting problem. Tell your doctor if you get any unexplained bleeding or bruising. • Possible harm to your unborn baby. Sirolimus can harm your unborn baby. You should not become pregnant during treatment with sirolimus and for 12 weeks after ending treatment with sirolimus. See "What should I tell my doctor before taking sirolimus?". The most common side effects of sirolimus in people with renal transplant include:
| •high blood pressure •pain (including stomach and joint pain) •diarrhea •headache •fever | •urinary tract infection •low red blood cell count (anemia) •nausea •low platelet count (cells that help blood to clot) •high blood sugar (diabetes)
7 unchanged lines

Instructions for use

Changed4 words added, 4 removed
10 unchanged lines
Each sirolimus oral solution carton contains:
| a)1.a 2 oz. (60 mL fill) amber glass bottle of sirolimus (concentration of 1 mg/mL) b)2.1 oral syringe adapter for fitting into the neck of the bottle c)3.enough disposable oral syringes (amber color) and caps for daily dosing d)4.1 carrying case
You will also need:
9 unchanged lines
How should I store sirolimus?
• Store bottles of sirolimus oral solution in the refrigerator at 36°F to 46°F (2°C to 8°C).
•Protect from light.
8 unchanged lines

PRINCIPAL DISPLAY PANEL - Kit Carton

Changedpunctuation or symbols only
11 unchanged lines
Each sirolimus oral solution carton contains:
• A 2 oz. (60 mL fill) amber glass bottle of sirolimus (concentration of 1 mg/mL)
•1 oral syringe adapter for fitting into the neck of the bottle
6 unchanged lines

Unchanged: Boxed warning, Indications and usage, Dosage and administration, Dosage forms and strengths, Contraindications, Warnings and precautions, Adverse reactions, Use in specific populations, Overdosage, Description, Clinical pharmacology, Nonclinical toxicology, Clinical studies, References, How supplied, Untitled section, PRINCIPAL DISPLAY PANEL - 60 mL Bottle Label, PRINCIPAL DISPLAY PANEL - 60 mL Bottle Carton.

Every version

15 versions of set 384cb547-55a4-47fc-a0a6-054c18a51b84, newest first.
VersionPublished on DailyMedCompareSPL file
20Oct 26, 2026Shown belowDownload .zip
19Oct 14, 2026With version 18Download .zip
18Sep 24, 2026With version 17Download .zip
17May 29, 2025With version 16Download .zip
16Dec 2, 2024With version 15Download .zip
15Nov 22, 2023With version 14Download .zip
14Sep 21, 2022With version 13Download .zip
13Jul 7, 2021With version 11Download .zip
11Oct 7, 2020With version 10Download .zip
10Jan 31, 2020With version 9Download .zip
9Oct 17, 2019With version 8Download .zip
8Sep 30, 2019With version 7Download .zip
7Sep 10, 2019With version 5Download .zip
5Nov 23, 2016With version 3Download .zip
3Jun 15, 2016First versionDownload .zip

Read an SPL file

Open an SPL label file

Drop a Structured Product Labeling .xml file, or the .zip DailyMed downloads, to read it as a label. It is read in this browser tab and not uploaded.

Read in this browser tab; nothing is uploaded.

Versions and label text from DailyMed's SPL web services; a version's text is read from its SPL file, so it matches what DailyMed shows. Recent safety-related changes from FDA's Safety-related Labeling Changes database, which covers NDAs and CDER biologics, not generics. Lists refresh daily. DailyMed, National Library of Medicine

About label change history

How to read a comparison

Sections that changed come first, in the order a reviewer reads a label: boxed warning, recent major changes, indications, dosage, contraindications, warnings and precautions, adverse reactions, then the rest. Each shows the changed lines with one unchanged line either side; longer unchanged stretches are folded into a count. Table rows read left to right with cells separated by a bar.

The comparison covers the label text. Images, product data (NDC codes, ingredients, packaging) and formatting are not compared.

Which label is shown

A drug can have several labels: one per brand-name application (Ozempic, Wegovy and Rybelsus are three), and copies from repackagers. For each NDA or BLA the page takes the DailyMed set with the most versions, which is the application holder's. Generic labels are left out; they follow the brand's label.

Frequently asked questions

Where do the versions come from?
DailyMed, the National Library of Medicine's library of labels in Structured Product Labeling (SPL) format. Each time a company submits a revised label, DailyMed publishes it as a new version of the same set and keeps the old ones.
Is a new version a new FDA approval?
Not always. Companies also submit new versions for changes that need no FDA approval first, such as a new address, a new package size or a corrected typo. Safety changes FDA approved are listed in its Safety-related Labeling Changes database, linked below.
Why does the published date differ from the label's revised date?
The published date is when DailyMed posted the version. The label's own revised date, at the end of the highlights, is when the company revised the text, usually a few days to weeks earlier.
How is the comparison made?
Each section is matched by its standard LOINC code, then split into headings, paragraphs, list items and table rows. Lines are aligned with a longest-common-subsequence diff; a removed and an added line that share at least half their words are shown as one edited line with the changed words marked. Curly quotes, dash styles and spacing are ignored.
Is my SPL file uploaded?
No. A file you drop on this page is read in your browser tab and never sent to Arca.
Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.